← Product Code [CAH](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CAH) · K973797 # BREATHING CIRCUIT BACTERIAL FILTER (K973797) _King Systems Corp. · CAH · Mar 12, 1998 · Anesthesiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94therapeutic-devices/CAH/K973797 ## Device Facts - **Applicant:** King Systems Corp. - **Product Code:** [CAH](/submissions/AN/subpart-f%E2%80%94therapeutic-devices/CAH.md) - **Decision Date:** Mar 12, 1998 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 868.5260 - **Device Class:** Class 2 - **Review Panel:** Anesthesiology ## Indications for Use A bacterial filter is indicated for use when the care provider desires to protect the patient, care provider, equipment, or all three from the transference of bacteria or virus through the breathing circuit. This filter is provided only in combination with a King Systems Universal F2™ breathing circuit. Within this combination the overall intended use is to administer medical gases and/or anesthetic gases to a patient during anesthesia for inhalation, or medical gases to a patient during respiratory care inhalation. ## Device Story Breathing circuit bacterial filter; used in combination with King Systems Universal F2 breathing circuit. Function: filtration of bacteria/viruses from gas flow within breathing circuit. Application: anesthesia or respiratory care inhalation. Operation: passive filtration during gas delivery. Benefit: reduces risk of cross-contamination between patient, provider, and equipment. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Bacterial filter for integration into breathing circuits. Mechanical filtration principle. Designed for use with King Systems Universal F2 breathing circuit. ## Regulatory Identification A breathing circuit bacterial filter is a device that is intended to remove microbiological and particulate matter from the gases in the breathing circuit. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the circumference. Inside the circle is a stylized image of an eagle or bird-like figure with outstretched wings. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 MAR 1 2 1998 Mr. Bruce E. Green King Systems Corporation 15011 Herriman Boulevard Noblesville, IN 46060 Re: K973797 Breathing Circuit Bacterial Filter Regulatory Class: II (two) Product Code: 73 CAH Dated: January 7, 1998 Received: January 8, 1998 Dear Mr. Green: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 EFR Part-820) and that; through periodic=(QS) ========================================================================================================= inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {1}------------------------------------------------ Page 2 - Mr. Bruce E. Green This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Thomas J. Callabrin, Ph.D. Thomas J. Callahan, Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ Image /page/2/Picture/0 description: The image shows the words "KING SYSTEMS" in large, bold, sans-serif font. Below that, in a smaller font, is the word "CORPORATION". The text is all in black and the background is white. The words are stacked on top of each other. Revised February 3, 1998 510(K) #K973797 Device Name: Breathing Circuit Bacterial Filter Indications For Use: A bacterial filter is indicated for use when the care provider desires to protect the patient, care provider, equipment, or all three from the transference of bacteria or virus through the breathing circuit. This filter is provided only in combination with a King Systems Universal F2™ breathing circuit. Within this combination the overall intended use is to administer medical gases and/or anesthetic gases to a patient during anesthesia for inhalation, or medical gases to a patient during respiratory care inhalation. Suan E. Free Bruce E. Green Regulatory Affairs Manager 11 ision Sign-Off) on of Cardiovascular, Respiratory, Surological Devices 19737 (k) Number _ Prescriptions use \$\checkmark\$ TC 1501 1 HERRIMAN BOULEVARD / NOBLESVILLE, IN 46060 PHONE 317-776-6823 1-800-642-5464 FAX 317-776-6827 E-Mail: kingsystems@iquest.net World Wide Web: www.kingsystems.com --- **Source:** [https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94therapeutic-devices/CAH/K973797](https://fda.innolitics.com/submissions/HO/subpart-f%E2%80%94therapeutic-devices/CAH/K973797) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com